Regentis Biomaterials (RGNT) Gains from Investment Securities (2024 - 2025)
Regentis Biomaterials (RGNT) reported Gains from Investment Securities of $965000.0 for Q4 2025, up 1117.05% year-over-year from $79290.0 in Q4 2024, and up 1117.05% quarter-over-quarter from $79290.0 in Q4 2024.
Regentis Biomaterials (RGNT) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Gains from Investment Securities data on file, last reported at $965000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $965000.0, up 1117.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $965000.0 (up 1117.05% YoY), and the FY2025 annual result was $965000.0, up 1117.05% from the prior year.
- Gains from Investment Securities rose to $965000.0 in Q4 2025 per RGNT's latest filing, from $79290.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $965000.0 in Q4 2025 and troughed at $79290.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Regentis Biomaterials | 3.72 Mn | -3.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 965,000.00 |
| Dec 31, 2025 | 965,000.00 |
| Dec 31, 2024 | 79,290.00 |
| Dec 31, 2024 | 79,290.00 |